How to find out how long the patent protection period of drugs is?

Drug patent is undoubtedly one of the core points of pharmaceutical companies, with high complexity. If you want to thoroughly analyze the original patent, you need professionals. The main purpose of patent investigation is to avoid infringement. You need to sort out information such as the patentee, legal status, patent type and application date. The starting date of patent protection is from the date of application, not from the date of patent authorization. There are three kinds of patents, namely invention, utility model and design. The protection period of the invention is 20 years.

There are many ways to inquire about the expiration of drug patents, such as through the orange book of fda, through the US Food and Drug Administration in Europe, and through professional databases to inquire about the patent protection period. Here is a brief introduction to the query method.

Queries in the database

The query in the database orange book can be carried out by keyword search such as trade name, active ingredient, application number, application company and approval date.

Patent data can also be screened out according to whether there are patents, reference preparations, reference preparations and market conditions. In addition to searching for a single option, you can also search for the combination of multiple options, make full use of artificial intelligence technology, understand the global medical patent information from different dimensions, and grasp the latest global medical trends.

Retrieval method of drug patent protection period

After filtering out the patent data, click the product name to enter the visual details page, and check the patent expiration time in the patent data below. However, these are all American patents, and they may not be authorized in China, so the next step is to know the application and approval in China through the patent inquiry of the same family.

Then go to the global medical patent database to query, and you can search the global medical patent information through the dimensions of patent publication number, patent name, patentee, indication, drug name, patent first publication date, patent application date, first priority number, first priority date, patent of the same family 10, etc. In addition to searching for a single option, you can also combine multiple options to make full use of artificial intelligence technology from different dimensions.

Screening method of drug patent protection period

The search results cover six dimensions of data information: patent publication number, patent name, patentee, indication (middle), patent application date and patent first publication date. The data sources are all from authoritative organizations and officials, and the data results have important value and reference significance.

Search results

Click on the patent publication number to enter the details page, where you can inquire about the patents of the same subject and learn about the data of drug patent protection period.

Patent protection period

During the period of drug patent protection

Generic drug companies will not honestly wait for your original drug patent to expire before listing. They will try their best to get the approval of listing in advance and pass the patent challenge of section IV in the United States. This is also allowed by laws and regulations.

Generally speaking, an original drug can not be challenged except for the compound patent (expired first), and other patents including crystal form, preparation and application may be challenged. Once the challenge is successful, the patent will be terminated, and generic drugs can be listed in advance to obtain huge benefits.

The above is how to inquire about the specific method of drug patent protection period. Patent data is very important and is one of the core points of a pharmaceutical company. If generic drugs are not listed, the price of the original drug will gradually decline, which will lead to the withdrawal of the original drug from the market and basically leave it to generic drugs. After all, the logic of making money by original pharmaceutical companies is different from that of generic drugs. It is the original pharmaceutical company that obtains excess profits through the protection period, so it is necessary to thoroughly understand the patent data of drugs at this point.